Search
Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery
Publication
Jacobs S,
Bunt C,
Wu Z,
Lehr C,
Rupenthal I
(2012)
Drug Development and Industrial Pharmacy, 38, 11, 1337-1343, 10.3109/03639045.2011.650646
Drug Development and Industrial Pharmacy, 38, 11, 1337-1343, 10.3109/03639045.2011.650646
Overview of Inhaled Nanopharmaceuticals
Publication
Barthold S,
Kunschke N,
Murgia X,
Loretz B,
Carvalho-Wodarz C,
Lehr C
(2023)
Journal of aerosol medicine and pulmonary drug delivery, 36, 3, 144-151, 10.1089/jamp.2023.29089.sb, 37310368
Journal of aerosol medicine and pulmonary drug delivery, 36, 3, 144-151, 10.1089/jamp.2023.29089.sb, 37310368
Influence of particle size and material properties on mucociliary clearance from the airways
Publication
Henning A,
Schneider M,
Nafee N,
Muijs L,
Rytting E,
Wang X,
Kissel T,
Grafahrend D,
Klee D,
Lehr C
(2010)
Journal of aerosol medicine and pulmonary drug delivery, 23, 4, 233-241, 10.1089/jamp.2009.0806
Journal of aerosol medicine and pulmonary drug delivery, 23, 4, 233-241, 10.1089/jamp.2009.0806
Metabolic profiling of S-praziquantel: Structure elucidation using the crystalline sponge method in combination with mass spectrometry and nuclear magnetic resonance
Publication
Rosenberger L,
Jenniches J,
Essen C,
Khutia A,
Kühn C,
Marx A,
Georgi K,
Hirsch A,
Hartmann R,
Badolo L
(2022)
Drug metabolism and disposition: the biological fate of chemicals, 10.1124/dmd.121.000663, 35115299
Drug metabolism and disposition: the biological fate of chemicals, 10.1124/dmd.121.000663, 35115299
About
Page
Who we are The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) was established in August 2009 in collaboration between the Helmholtz Centre for Infection Research (HZI) and the Saarlan
Management
Page
Management Institute Management Administrative Team Scientific Advisory Board Since its foundation in 2009, Prof. Rolf Müller leads the HIPS as its Managing Director. Since 2019, Dr. Stephanie Thomas
Yields and Immunomodulatory Effects of Pneumococcal Membrane Vesicles Differ with the Bacterial Growth Phase
Publication
Mehanny M,
Kroniger T,
Koch M,
Hoppstädter J,
Becher D,
Kiemer A,
Lehr C,
Fuhrmann G
(2022)
Advanced healthcare materials, 11, 5, 10.1002/adhm.202101151, 34724354
Advanced healthcare materials, 11, 5, 10.1002/adhm.202101151, 34724354
Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization
Publication
Mehanny M,
Boese A,
Bornamehr B,
Hoppstädter J,
Presser V,
Kiemer A,
Lehr C,
Fuhrmann G
(2022)
International journal of pharmaceutics, 621, 10.1016/j.ijpharm.2022.121794, 35525468
International journal of pharmaceutics, 621, 10.1016/j.ijpharm.2022.121794, 35525468
Exploring the permeation of fluoroquinolone metalloantibiotics across outer membrane porins by combining molecular dynamics simulations and a porin-mimetic in vitro model
Publication
Sousa C,
Coimbra J,
Richter R,
Morais-Cabral J,
Ramos M,
Lehr C,
Fernandes P,
Gameiro P
(2022)
Biochimica et biophysica acta. Biomembranes, 1864, 3, 10.1016/j.bbamem.2021.183838, 34896074
Biochimica et biophysica acta. Biomembranes, 1864, 3, 10.1016/j.bbamem.2021.183838, 34896074
Analysis and Optimization of Two Film-Coated Tablet Production Processes by Computer Simulation: A Case Study
Publication
Hering S,
Schäuble N,
Buck T,
Loretz B,
Rillmann T,
Stieneker F,
Lehr C
(2021)
Processes, 9, 1, 10.3390/pr9010067
Processes, 9, 1, 10.3390/pr9010067